Medine.co.uk

Forketos Oral Solution For Cattle And Sheep

Revised: 25 June 2008

AN: 02094/2007


SUMMARY OF PRODUCT CHARACTERISTICS

1.

NAME OF THE VETERINARY MEDICINAL PRODUCT


Forketos Oral Solution for Cattle and Sheep

2.

QUALITATIVE AND QUANTITATIVE COMPOSITION


Active substances

Qualitative composition

Propylene glycol

Cobalt sulphate heptahydrate

(Equivalent to 0.21 mg/ml elemental cobalt)


Excipients

For a full list of excipients, see section 6.1.


Quantitative composition

80 % v/v

0.1 % w/v


3.

PHARMACEUTICAL FORM


Oral solution.

A clean, bright, pale pink, odourless solution.

4.

CLINICAL PARTICULARS

4.1

Target species


Cattle and sheep.

4.2

Indications for use, specifying the target species


As an aid in the treatment of acetonaemia (ketosis) in cattle and pregnancy toxaemia in sheep.

4.3

Contraindications


None known.

4.4

Special warnings for each target species


No special warnings.

4.5

Special precautions for use

i.

Special precautions for use in animals


None known.

ii.

Special precautions for the person administering the veterinary medicinal product to animals


In case of accidental eye contact, wash eyes with plenty of clean water. If irritation occurs, seek medical attention.

In case of contact with skin, remove any contaminated clothing and wash affected area thoroughly with soap and water. If irritation occurs seek medical advice.

Wash hands after use.

4.6

Adverse reactions (frequency and seriousness)


None known.

4.7

Use during pregnancy, lactation or lay


No special precautions.

4.8

Interaction with other medicinal products and other forms of interaction


None known.

4.9

Amount(s) to be administered and administration route


To be administered orally as a drench.


Cattle: 150 - 200 ml twice daily for 3 - 4 days.

Sheep: 2 ml/kg bodyweight up to a maximum of 120 ml.


This dose may be repeated 7 - 8 hours later if necessary.

Do not exceed stated dose.

4.10

Overdose (symptoms, emergency procedures, antidotes), if necessary


Propylene glycol toxicity can result in incoordination and narcosis. Signs of cobalt overdose are loss of weight, anorexia and muscular incoordination.

4.11

Withdrawal period(s)


Meat: zero days

Milk: zero hours

5.

PHARMACOLOGICAL PROPERTIES



Pharmacotherapeutic group:



Drugs for treatment of acetonaemia.


ATC Vet Code:


QA16QA01

5.1

Pharmacodynamic properties


Propylene glycol is a glucose precursor. Cobalt is an essential trace element.

5.2

Pharmacokinetic properties


Propylene glycol is metabolised and excreted rapidly. Cobalt is converted in the rumen to Vitamin B12 by bacterial flora.


6.

PHARMACEUTICAL PARTICULARS

6.1

List of excipients


Water, purified

6.2

Incompatibilities


None known.

6.3

Shelf life


Shelf life of the veterinary medicinal product as packaged for sale: 3 years.

6.4

Special precautions for storage


Do not store above 25°C

Protect from light.

Protect from frost.

6.5

Nature and composition of immediate packaging


1 litre and 25 litre high density polyethylene bottles with a high density polyethylene cap (screw fit).

Not all pack sizes may be marketed.

6.6

Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products, if appropriate


Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.

7.

MARKETING AUTHORISATION HOLDER


Dechra Limited

Dechra House

Jamage Industrial Estate

Talke Pits

Stoke-on-Trent

Staffordshire

ST7 1XW

8.

MARKETING AUTHORISATION NUMBER(S)


10434/4036


9.

DATE OF FIRST AUTHORISATION


09/06/1993


10.

DATE OF REVISION OF THE TEXT


25 June 2008